08/14/2025
9:35 AM | Altium Capital Management LLC (Filed by)
Sunshine Biopharma (Subject)
Sunshine Biopharma Inc. (Subject)
| Form SCHEDULE 13G/A | |
08/12/2025
11:15 PM | Sunshine Biopharma (Filer)
Sunshine Biopharma Inc. (Filer)
| Form EFFECT | |
08/12/2025
3:45 PM | Sunshine Biopharma (Filer)
Sunshine Biopharma Inc. (Filer)
| Form 424B3 | |
08/12/2025
3:56 PM | Sunshine Biopharma (Filer)
Sunshine Biopharma Inc. (Filer)
| Form 10-Q
General form for quarterly reports under Section 13 or 15(d) | |
06/12/2025
7:24 PM | BIGGER CAPITAL FUND L P (Filed by)
Sunshine Biopharma (Subject)
Sunshine Biopharma Inc. (Subject)
| Form SCHEDULE 13G/A | |
05/15/2025
3:06 PM | Sunshine Biopharma (Filer)
Sunshine Biopharma Inc. (Filer)
| Form 10-Q
General form for quarterly reports under Section 13 or 15(d) | |
04/03/2025
11:02 AM | Sunshine Biopharma (Filer)
Sunshine Biopharma Inc. (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
04/03/2025
9:46 AM | Sunshine Biopharma (Filer)
Sunshine Biopharma Inc. (Filer)
| Form 424B5 | |
04/02/2025
9:50 AM | Sunshine Biopharma (Filer)
Sunshine Biopharma Inc. (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
04/01/2025
4:05 PM | Sunshine Biopharma (Filer)
Sunshine Biopharma Inc. (Filer)
| Form 10-K
Annual report pursuant to Section 13 or 15(d) | |
03/31/2025
3:05 PM | Sunshine Biopharma (Filer)
Sunshine Biopharma Inc. (Filer)
| Form NT 10-K | |
Get the Latest News and Ratings for SBFM and Related Stocks Enter your email address below to receive the latest news and analysts' ratings for Sunshine Biopharma and its competitors with MarketBeat's FREE daily newsletter. |
02/14/2025
3:43 PM | L1 Capital Global Opportunities Master Fund, Ltd. (Filed by)
Sunshine Biopharma (Subject)
Sunshine Biopharma Inc. (Subject)
| Form SCHEDULE 13G/A | |
01/21/2025
7:20 AM | Roy Michel (Reporting)
Sunshine Biopharma (Issuer)
Sunshine Biopharma Inc. (Issuer)
| Form 3
Initial statement of beneficial ownership of securities | |
01/15/2025
11:15 PM | Sunshine Biopharma (Filer)
Sunshine Biopharma Inc. (Filer)
| Form EFFECT | |
01/15/2025
7:30 AM | Sunshine Biopharma (Filer)
Sunshine Biopharma Inc. (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
01/06/2025
10:44 AM | Sunshine Biopharma (Filer)
Sunshine Biopharma Inc. (Filer)
| Form S-3
Registration statement under Securities Act of 1933 | |
12/10/2024
3:26 PM | Sunshine Biopharma (Filer)
Sunshine Biopharma Inc. (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
11/14/2024
3:28 PM | ARMISTICE CAPITAL, LLC (Filed by)
Sunshine Biopharma (Subject)
Sunshine Biopharma Inc. (Subject)
| Form SC 13G/A | |
11/12/2024
10:29 AM | Sunshine Biopharma (Filer)
Sunshine Biopharma Inc. (Filer)
| Form 424B4 | |
11/07/2024
3:40 PM | Sunshine Biopharma (Filer)
Sunshine Biopharma Inc. (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
11/06/2024
12:43 PM | Sunshine Biopharma (Filer)
Sunshine Biopharma Inc. (Filer)
| Form POS AM | |
11/05/2024
3:05 PM | Sunshine Biopharma (Filer)
Sunshine Biopharma Inc. (Filer)
| Form 10-Q
General form for quarterly reports under Section 13 or 15(d) | |
10/23/2024
3:05 PM | Sunshine Biopharma (Filer)
Sunshine Biopharma Inc. (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
09/10/2024
3:05 PM | Sunshine Biopharma (Filer)
Sunshine Biopharma, Inc (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
08/19/2024
3:05 PM | Sunshine Biopharma (Filer)
Sunshine Biopharma, Inc (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
MarketBeat All Access